Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,496,527 papers from all fields of science
Search
Sign In
Create Free Account
SNHG16 gene
Known as:
small nucleolar RNA host gene 16
, ncRAN
, SNHG16
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
LncRNA SNHG16 Promotes the Progression of Laryngeal Squamous Cell Carcinoma by Mediating miR-877-5p/FOXP4 Axis
Xiaoli Wang
,
Limin Liu
,
Wenfei Zhao
,
Qingyan Li
,
Guangsheng Wang
,
Hua-hui Li
OncoTargets and Therapy
2020
Corpus ID: 219480424
Objective Laryngeal cancer is a common malignant tumor in the ENT, of which laryngeal squamous cell carcinoma (LSCC) accounts for…
Expand
2020
2020
Up‐regulation of SNHG16 induced by CTCF accelerates cardiac hypertrophy by targeting miR‐182‐5p/IGF1 axis
Dong Wang
,
Bin Lin
,
Wen Zhang
,
Xiaofeng Wang
Cell Biology International
2020
Corpus ID: 211831628
Long non‐coding RNA (lncRNA) SNHG16 has been reported to be significant regulators in multiple cancers. However, never has the…
Expand
2020
2020
LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
J-Q Guo
,
Z-J Yang
,
S. Wang
,
Z-Z Wu
,
L-L Yin
,
D-C Wang
European Review for Medical and Pharmacological…
2020
Corpus ID: 261301086
OBJECTIVE Recently, the role of long noncoding RNAs (lncRNAs) is vital in tumor progression. Our study aims to identify the role…
Expand
2020
2020
LncRNA SNHG16 Promotes Proliferation, Migration, and Invasion of Glioma Cells Through Regulating the miR-490/PCBP2 Axis.
Fangen Kong
,
Yang Yan
,
+4 authors
Yiping Wang
Cancer Biotherapy and Radiopharmaceuticals
2020
Corpus ID: 220841888
Background: Glioma is the most common tumor of the central nervous system, which has a high mortality and recurrence rate…
Expand
2020
2020
Bupivacaine-Induced Neurotoxicity Is Modulated by Epigenetic Axis of Long Noncoding RNA SNHG16 and Hsa-miR-132-3p
Lei Guan
,
Tianzuo Li
,
Jingwen Jiang
Neurotoxicity research
2020
Corpus ID: 216111424
Clinical application of local anesthetic reagent, liposomal bupivacaine (BUP), may cause irreversible damage to human nerve…
Expand
2020
2020
Erratum: LncRNA SNHG16 induced by TFAP2A modulates glycolysis and proliferation of endometrial carcinoma through miR-490-3p/HK2 axis.
Guangyu Zhang
,
Anjun Ma
,
Yuqin Jin
,
Guoyou Pan
,
Cong Wang
American journal of translational research
2020
Corpus ID: 219537817
[This corrects the article on p. 7137 in vol. 11, PMID: 31814916.].
2020
2020
Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
X-S Zhao
,
N. Tao
,
C. Zhang
,
Cuixue Gong
,
C-Y Dong
European Review for Medical and Pharmacological…
2020
Corpus ID: 218520836
OBJECTIVE Recently, the role of long noncoding RNA (lncRNAs) in tumor progression has attracted much attention. The aim of this…
Expand
Review
2020
Review
2020
Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
X-S Zhao
,
N. Tao
,
C. Zhang
,
Cuixue Gong
,
C-Y Dong
European Review for Medical and Pharmacological…
2020
Corpus ID: 220941053
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to…
Expand
2019
2019
NRAS Contributes to Retinoblastoma Progression Through SNHG16/miR-183-5p/NRAS Regulatory Network
Guangli Sun
,
Gang Su
,
Fang Liu
,
Wenjie Han
OncoTargets and Therapy
2019
Corpus ID: 209325978
Purpose The oncogene of wild type neuroblastoma RAS viral oncogene homolog (NRAS) has been found to involve in the tumorigenesis…
Expand
2017
2017
WITHDRAWN: SNHG16 indicates a poor prognosis and affects cell proliferation, migration and invasion in non-small cell lung cancer.
W. Han
,
X. Du
,
Jing Wang
,
Lixin Sun
,
Yongchun Li
Experimental Cell Research
2017
Corpus ID: 214733687
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE